Aegerion Pharmaceuticals Inc., a Bridgewater, N.J.-based drug company focused on cardiovascular and metabolic disease, has withdrawn registration of an IPO designed to raise upwards of $70 million. It blamed “market conditions” for the decision. Lehman Brothers had been serving as lead underwriter. Aegerion raised around $22.5 million in Series A funding in 2005 from firms like Alta Partners, Advent International, Index Ventures, MVM Life Science Partners and Scheer & Co.
Amsterdam Molecular Therapeutics Holding BV, a Dutch gene therapy company, has set its proposed IPO terms to 5 million common shares being offered at €10 per share. The company plans to trade on the Euronext, and would be valued at nearly €140 million. It raised a €22 million Series A round last fall from ABN Amro Capital, Advent Venture Partners, Gilde Healthcare Partners and Crédit Agricole Private Equity.
Ascendas India Trust, owned by a Singaporean office and industrial parks manager, plans to raise up to $325 million in a Singapore listing in July. Ascendas India, which last week launched a $325 million property fund focused on Indian office projects will sell 425.3 million shares with an overallotment option of 10 percent. The funds investors include Bahrain-based asset manager Arcapita, and the Dutch bank ING’s Private Banking arm.
Basell has agreed to acquire Salt Lake City-based chemicals company Huntsman Corp. (NYSE: HUN) for $5.6 billion in cash. The total transaction value is $9.6 billion, including assumed debt. The Huntsman family and MatlinPatterson Global Advisors are Huntsman’s majority shareholders.
Biofuel Energy Corp., a Denver-based ethanol producer, raised $55 million in its IPO, by pricing 5.25 million common shares at $10.50 per share. It originally filed to raise $300 million, by pricing 9.5 million shares at between $16 and $18 per share (later revised downward to $13-$14). The IPO gives BioFuel a market cap of around $340 million. It will trade on the Nasdaq under ticker symbol BIOF, while JPMorgan, Citigroup and A.G. Edwards served as co-lead underwriters. Shareholders include Greenlight Capital, Third Point Partners and Cargill Inc.
BWAY Holding Co., an Atlanta-based manufacturer of rigid metal and plastic containers, raised $150.6 million via its IPO, by pricing 10.04 million common shares at $15 per share ($16-$18 range). The IPO values BWAY at approximately $324 million. It will trade on the NYSE under ticker symbol BWY, while Goldman Sachs and Banc of America served as co-lead underwriters. Kelso & Co. acquired BWAY in 2003, and sold around 40 percent of its shares as part of the IPO.
Data Domain Inc., a Santa Clara, Calif.-based provider of storage appliances for disk-based backup and network-based disaster recovery, raised $110.85 million in its IPO. It priced 7.39 million common shares at $15 per share ($11.50-$13.50 range), for an initial valuation of around $777 million. It will trade on the Nasdaq under ticker symbol DDUP, while Goldman Sachs and Morgan Stanley served as co-lead underwriters. Data Domain had raised around $41 million in VC funding since 2002, from firms like Greylock Partners (30.3 percent pre-IPO stake), New Enterprise Associates (28.9 percent), Sutter Hill Ventures (16.8 percent) and HRJ Capital.
Dice Holdings Inc., an Urbandale, Iowa–based provider of specialized career sites and career fairs, has set its proposed IPO terms to 16.7 million common shares being offered at between $11 and $13 per share. Dice would be valued at approximately $805 million, if it were to price at the high end of its range. It plans to trade on the NYSE, with Credit Suisse and Morgan Stanley serving as co-lead underwriters. Dice has been owned by General Atlantic and Quadrangle Group since August 2005.
Geovera Insurance Holdings Ltd., a Bermuda-based residential property insurer, said that its $115 million IPO has been postponed indefinitely due to “market conditions.” JPMorgan and Merrill Lynch are serving as co-lead underwriters. Shareholders include Hellman & Friedman (65.1 percent pre-IPO stake) and Friedman Fleischer & Lowe (32.5 percent).
Lululemon Corp., a Vancouver-based athletic apparel designer and retailer, has set its proposed IPO terms to around 18.18 million common shares being offered at between $10 and $12 per share. It would be valued at around $903 million, were it to price at the high end of its range. Lululemon plans to trade on both the Nasdaq and TSX, with Goldman Sachs and Merrill Lynch serving as co-lead underwriters. Shareholders include Advent International, Highland Capital Partners and Brooke Private Equity Advisors.
PROS Holdings Inc., a Houston, Texas-based provider of pricing and revenue optimization software, has set its proposed IPO terms to 6.825 million common shares being offered at between $10 and 412 per share. If it prices at the high end, it would be valued at approximately $309.5 million. PROS plans to trade on the Nasdaq under ticker symbol PROZ, with JPMorgan and Deutsche Bank Securities serving as co-lead underwriters. Shareholders include TA Associates (35.6 percent pre-IPO stake) and JMI Equity (11.2 percent).
SS&C Technologies Inc., a Windsor, Conn.-based financial management software provider owned by The Carlyle Group, has filed for a $200 million IPO. It plans to trade on the Nasdaq under ticker symbol SSNC, with Morgan Stanley, Credit Suisse and Morgan Stanley serving as co-led underwriters. SS&C reported 2006 revenue of approximately $205.5 million.